No, Evolut had a DVI of 0.61, we had 0.62.
its interesting to note Evolut has superior metrics to Sapien, yet Sapien has greater market share.
Ann: 30-day Haemodynamic Results from the DurAVR US EFS Trial, page-40
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.52 |
Change
-0.190(1.21%) |
Mkt cap ! $301.9M | |||
| Open | High | Low | Value | Volume |
| $15.72 | $15.75 | $15.52 | $18.09K | 1.157K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 607 | $15.52 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.91 | 151 | 4 |
View Market Depth
| Last trade - 11.42am 26/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |